Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
about
MicroRNA Dysregulation in Cystic FibrosisPharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammationmiRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6.Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
P2860
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Targeting miRNA-based medicine ...... ial cells using nanotechnology
@en
Targeting miRNA-based medicine ...... al cells using nanotechnology.
@nl
type
label
Targeting miRNA-based medicine ...... ial cells using nanotechnology
@en
Targeting miRNA-based medicine ...... al cells using nanotechnology.
@nl
prefLabel
Targeting miRNA-based medicine ...... ial cells using nanotechnology
@en
Targeting miRNA-based medicine ...... al cells using nanotechnology.
@nl
P2860
P50
P356
P1476
Targeting miRNA-based medicine ...... ial cells using nanotechnology
@en
P2093
Orla Cunningham
P2860
P304
P356
10.2147/IJN.S47551
P407
P577
2013-10-11T00:00:00Z